Lion's Mane
In short
Summary of findings for quick reference
Lion's Mane is an edible mushroom with distinctive white spines, known as hou tou gu in China and yamabushitake in Japan. Modern sources describe culinary use and traditional digestive uses, without establishing a precise historical starting date. It also grows in central Europe but is rare in Austria.
Some constituents affect a signalling protein important to certain nerve cells in laboratory experiments. This explains scientific interest but does not show that eating the mushroom improves memory or regenerates damaged human nerves. The visible fruiting body, its network of fungal threads and their extracts also differ in composition.
Human studies are small and involve different preparations and populations. One trial found improved test scores in mild cognitive impairment, followed by declining scores after treatment stopped. Other findings are mixed. This evidence does not support a reliable treatment recommendation.
Clinical evidence ↔ Historical significanceWe display two separate evidence categories: clinical evidence from modern trials and historical significance from documented healing tradition. Both are valuable, but they answer different questions.Read more
In every encyclopedia entry we evaluate two distinct categories of evidence. Clinical evidence as used in trials meets a narrower but scientifically essential bar. At the same time, the hundreds of thousands of plant species worldwide have only partially been captured and tested in modern studies.
Alongside the trial picture our researchers compile a comprehensive overview of where and since when a plant has been used across different traditions of natural medicine. When a plant has been used as a medicinal plant in many cultures across many generations, that historical significance deserves to be visible too.
Our position: a truly informative overview emerges only when both categories sit side by side. We communicate transparently what counts as what.
Overview
Lion's Mane (Hericium erinaceus) is an edible mushroom with cream-white, hanging spines. It grows on hardwood trees and is also cultivated. Known as hou tou gu in China and yamabushitake in Japan, it is used as food in East Asia. Modern Chinese accounts also describe traditional medicinal uses.
Modern interest focuses on possible effects on memory and nerve cells, prompted by laboratory work on individual constituents. Small human trials provide preliminary, mixed findings. They do not establish a reliable benefit for healthy people or a treatment for memory disorders.
History
Chinese sources describe hou tou gu as food and, in modern accounts of traditional medicine, for stomach and digestive complaints. The sources available here do not securely date the beginning of medicinal use. In Japan the mushroom is known as the edible yamabushitake.
Lion's Mane also occurs in central Europe, with rare records from Austria. Occurrence alone does not establish use as a local household remedy. Since the early 1990s, researchers have investigated individual constituents in relation to nerve cells. These experiments and subsequent human trials should be distinguished from reported traditional uses.
Mechanism
Hericenones have been isolated from the fruiting body, the visible part of the mushroom; erinacines have been isolated from mycelium, its network of fungal threads. Individual compounds from these groups can stimulate nerve growth factor (NGF) production in laboratory experiments. NGF supports the survival and development of certain nerve cells.
These experiments explore possible mechanisms rather than establishing everyday benefits. Results for an isolated compound cannot automatically be transferred to the whole mushroom or every supplement. Whether the tested amounts produce the intended effects in humans remains uncertain. They do not establish reliable protection against dementia or regeneration of damaged nerves.
Mori and colleagues studied 30 adults with mild cognitive impairment in 2009. Scores were better with mushroom tablets than placebo at weeks 8, 12 and 16, then declined four weeks after treatment stopped. Saitsu and colleagues reported a benefit on one of three tests after 12 weeks in 2019. Nagano and colleagues studied women with various non-specific complaints in 2010. Differences in irritability and anxiety after four weeks were trends rather than statistically significant benefits over placebo.
The studies assess different abilities and complaints. Small samples and different preparations limit conclusions across trials. A positive test result does not automatically mean a noticeable benefit in daily life. The findings do not justify a general recommendation for memory disorders, anxiety or menopausal symptoms. Fruiting bodies, mycelium and concentrated extracts need separate assessment, including their food regulatory status.
Evidence
| Outcome | Class | Grade | Effect | Studies | Refs |
|---|---|---|---|---|---|
| Cognitive test scores in mild cognitive impairmentMori's small 2009 trial found better scores with mushroom tablets than placebo at weeks 8, 12 and 16. Scores declined four weeks after stopping. This is a preliminary finding in mild cognitive impairment, not proof of general memory benefits.30 adults aged 50 to 80 with mild cognitive impairment | EmergingEmerging research. Early small trials suggest an effect but await replication. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Preliminary Signal | [1] | |
| Nerve growth factor production in laboratory studiesIndividual hericenones from fruiting bodies and erinacines from mycelium have been studied for effects on NGF, a signalling protein that supports certain nerve cells. Cell and animal findings do not establish reliable human benefits.Cell culture and animal models | TraditionalTraditional use. Long-standing folk practice or EMA HMPC traditional-use monograph. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Lab Findings, Clinical Unclear | [7] | |
| Traditional Chinese medicinal and culinary useModern sources describe hou tou gu as food and a traditional remedy for digestive complaints. They establish neither a precise historical starting point nor clinical efficacy.Accounts of Chinese traditional use and East Asian cuisine | TraditionalTraditional use. Long-standing folk practice or EMA HMPC traditional-use monograph. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | Traditional use reported | ||
| Irritability and anxietyNagano 2010 randomised 30 women to mushroom or placebo cookies; 26 were analysed. At four weeks, differences in irritability and anxiety were trends, not statistically significant advantages over placebo. Participants were not specifically selected as a group with menopausal symptoms.Women with various non-specific complaints | InsufficientInsufficient data. No reliable trials or traditional sources available. | DEvidence quality grade D. Preliminary signal. A single small trial, pilot result, or laboratory or animal model. Clinical relevance unclear. This is an evidence rating, not a product endorsement. | No established advantage over placebo | [3] |
Usage
Forms and preparation
Fruiting bodies, mycelium and extracts are different materials. Their constituents also depend on strain and production. A dual extract uses water and alcohol; the term does not establish whether fruiting body, mycelium or both were used. The trials discussed here do not establish its superiority over other preparations. The fresh mushroom has a tender, somewhat seafood-like texture. Sauté it in butter or oil over moderate heat until cooked through and golden at the edges. Ground dried fruiting body can be cooked in soup. Supplement labels should identify the fungal material and distinguish powder from extract. A product description alone does not establish a health benefit.
Dosage
There is no generally established treatment dose. Mori used 3 g of tablets containing 96% dried mushroom powder daily, equivalent to 2.88 g powder, for 16 weeks in 2009. Nagano used 2 g fruiting-body powder daily in cookies for four weeks in 2010. These are study regimens, not dosing recommendations. One gram of extract cannot be assumed equivalent to 3 g mushroom powder. A safe upper amount for long-term use is not adequately established. A 2020 pilot did run for 49 weeks, but tested a specific erinacine A-enriched mycelial preparation in people with mild Alzheimer's disease. It does not establish a long-term regimen for other products or healthy people. Normal food portions are distinct from such study preparations.
Safety
Look-alikes
Similar plants and look-alikes
Hericium coralloides and Hericium americanum
Hericium coralloides also occurs in central Europe and forms distinctly branched, coral-like fruiting bodies. H. americanum is primarily known from eastern North America and is also branched. H. erinaceus usually forms a barely branched cushion. These are distinct species; resemblance alone does not justify transferring study results or approving a specimen for eating.
FAQs
Does Lion's Mane grow in Austria?
Yes, rare finds are documented in Austria. It grows on hardwood and is particularly associated with old beech and oak in central Europe. Local occurrence does not establish a household-remedy tradition. Leave rare wild specimens in place and use cultivated mushrooms for cooking.
Fruiting body or mycelium: what is the difference?
The fruiting body is the visible mushroom; mycelium is its network of fungal threads. Their composition differs and also depends on strain and processing. The studies discussed here do not establish a best form. Dual extraction uses water and alcohol; it does not automatically combine fruiting body and mycelium. Look for a clear description of the source material. Results for one preparation do not apply to all products.
What is NGF, and does the mushroom help memory?
NGF means nerve growth factor, a signalling protein that supports certain nerve cells. Individual fungal compounds can stimulate its production in laboratory experiments. That does not show that the mushroom regenerates damaged human nerves or reliably improves memory. Small studies provide preliminary findings on some tests; a reliable benefit in healthy people is not adequately established.
How long would an effect take?
There is no reliable prediction. The cognitive trials discussed here lasted twelve or sixteen weeks, but this is not a recommendation to take any supplement for that duration. A 49-week trial of a specific mycelial preparation in mild Alzheimer's disease does not answer the question for healthy people either. A duration that reliably produces noticeable everyday benefits has not been established.
7 sources.
- Koichiro Mori; Satoshi Inatomi; Kenzi Ouchi; Yoshihito Azumi; Takashi Tuchida. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. 2009. doi:10.1002/ptr.2634
- Yuusuke Saitsu; Akemi Nishide; Kenji Kikushima; Kuniyoshi Shimizu; Koichiro Ohnuki. Improvement of cognitive functions by oral intake of Hericium erinaceus.. 2019. doi:10.2220/biomedres.40.125
- Mayumi Nagano; Kuniyoshi Shimizu; Ryuichiro Kondo; Chickako Hayashi; Daigo Sato; Katsuyuki Kitagawa; Koichiro Ohnuki. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake.. 2010. doi:10.2220/biomedres.31.231
- I-Chen Li; Han-Hsin Chang; Chuan-Han Lin; Wan-Ping Chen; Tsung-Han Lu; Li-Ya Lee; Yu-Wen Chen; Yen-Po Chen; Chin-Chu Chen; David Pei-Cheng Lin. Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study. 2020. doi:10.3389/fnagi.2020.00155
- Koichiro Mori; Haruhisa Kikuchi; Yutaro Obara; Masaya Iwashita; Yoshihito Azumi; Satomi Kinugasa; Satoshi Inatomi; Yoshiteru Oshima; Norimichi Nakahata. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.. 2010. doi:10.1016/j.phymed.2010.05.004
- J. Koga; R. G. Thorn; E. Langer. A multilocus phylogeny of Hericium (Hericiaceae, Russulales). 2025. doi:10.3114/persoonia.2025.55.04
- Mendel Friedman. Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion's Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds. 2015. doi:10.1021/acs.jafc.5b02914
Legal notice: The depiction of historical significance and traditional use is context within our encyclopedia and not a health claim for any product, not a treatment promise, and not a substitute for medical advice. What may be stated on product labels, product pages, or in advertising is governed by the applicable legal requirements.